PCBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.376600E-01
Normal-vs-Stage2
3.710800E-01
Normal-vs-Stage3
2.143400E-01
Normal-vs-Stage4
5.251000E-01
Stage1-vs-Stage2
5.584200E-01
Stage1-vs-Stage3
5.919200E-01
Stage1-vs-Stage4
1.498770E-01
Stage2-vs-Stage3
1.598040E-01
Stage2-vs-Stage4
5.462400E-02
Stage3-vs-Stage4
1.142170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.722000E-01
Normal-vs-AfricanAmerican
5.173400E-01
Normal-vs-Asian
1.927770E-01
Caucasian-vs-AfricanAmerican
7.682000E-01
Caucasian-vs-Asian
2.767600E-01
AfricanAmerican-vs-Asian
3.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.932600E-01
Normal-vs-Female
3.062000E-01
Male-vs-Female
8.327000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.323600E-01
Normal-vs-Age(41-60Yrs)
4.222600E-01
Normal-vs-Age(61-80Yrs)
3.010200E-01
Normal-vs-Age(81-100Yrs)
6.447200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.068000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.023200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.929400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.309800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.088600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.851610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.067600E-01
Normal-vs-Daily Drinker
2.909600E-01
Normal-vs-Weekly Drinker
2.391400E-01
Normal-vs-Occasional Drinker
7.239400E-01
Normal-vs-Social Drinker
2.167600E-02
Non Drinker-vs-Daily Drinker
6.855200E-01
Non Drinker-vs-Weekly Drinker
4.880600E-01
Non Drinker-vs-Occasional Drinker
2.206200E-01
Non Drinker-vs-Social Drinker
5.021200E-01
Daily Drinker-vs-Weekly Drinker
7.320000E-01
Daily Drinker-vs-Occasional Drinker
1.071610E-01
Daily Drinker-vs-Social Drinker
8.883200E-01
Weekly Drinker-vs-Occasional Drinker
7.264200E-02
Weekly Drinker-vs-Social Drinker
7.786000E-01
Occasional Drinker-vs-Social Drinker
2.462500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.363380E-01
Normal-vs-Grade 2
2.958600E-03
Normal-vs-Grade 3
3.375600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.091580E-02
Grade 1-vs-Grade 3
2.404400E-03
Grade 1-vs-Grade 4
1.363380E-01
Grade 2-vs-Grade 3
4.312600E-01
Grade 2-vs-Grade 4
2.958600E-03
Grade 3-vs-Grade 4
3.375600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.738600E-01
Normal-vs-NonDiabetic
2.900400E-01
Diabetic-vs-NonDiabetic
5.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.038430E-01
Normal-vs-NoPancreatitis
3.609200E-01
Pancreatitis-vs-NoPancreatitis
6.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.199800E-01
Normal-vs-N1
4.439800E-01
N0-vs-N1
2.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.651500E-02
Normal-vs-TP53-NonMutant
1.590270E-04
TP53-Mutant-vs-TP53-NonMutant
1.384810E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
